Bufetolol

Last updated
Bufetolol
Bufetolol.svg
Bufetolol-3D-balls.png
Names
IUPAC name
1-(tert-Butylamino)-3-[2-(oxolan-2-ylmethoxy)phenoxy]propan-2-ol
Identifiers
3D model (JSmol)
ChEMBL
ChemSpider
KEGG
PubChem CID
UNII
Properties
C18H29NO4
Molar mass 323.433 g·mol−1
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
Infobox references

Bufetolol is a beta-adrenoceptor antagonist. [1]

Related Research Articles

Bisoprolol Beta blocker family of medications and is of the β1 selective type.

Bisoprolol, marketed under the tradename Zebeta among others, is a medication most commonly used for heart diseases. This specifically includes high blood pressure, chest pain from not enough blood flow to the heart, and heart failure. It is taken by mouth.

Beta-3 adrenergic receptor protein-coding gene in the species Homo sapiens

The beta-3 adrenergic receptor, also known as ADRB3, is a beta-adrenergic receptor, and also denotes the human gene encoding it.

Amibegron (SR-58,611A) was a drug developed by Sanofi-Aventis which acts as a selective agonist for the β3 adrenergic receptor. It is the first orally active β3 agonist developed that is capable of entering the central nervous system, and has antidepressant and anxiolytic effects.

Beta1-adrenergic agonists, also known as Beta1-adrenergic receptor agonists, are a class of drugs that bind selectively to the beta-1 adrenergic receptor. As a result, they act more selectively upon the heart. Beta-adrenoceptors typically bind to norepinephrine release by sympathetic adrenergic nerves and to circulating epinephrine. The effect of B-adrenoceptors is cardiac stimulation, such as increased heart rate, heart contractility, heart conduction velocity and heart relaxation.

Zinterol chemical compound

Zinterol is a beta-adrenergic agonist.

Tretoquinol chemical compound

Tretoquinol is a beta-adrenergic agonist.

Mabuterol chemical compound

Mabuterol is a selective β2 adrenoreceptor agonist.

Cyanopindolol chemical compound

Cyanopindolol is a drug related to pindolol which acts as both a β1 adrenoceptor antagonist and a 5-HT1A receptor antagonist. Its radiolabelled derivative iodocyanopindolol has been widely used in mapping the distribution of beta adrenoreceptors in the body.

ICI-118,551 chemical compound

ICI-118,551 is a selective β2 adrenergic receptor (adrenoreceptor) antagonist or beta blocker. ICI binds to the β2 subtype with at least 100 times greater affinity than β1 or β3, the two other known subtypes of the beta adrenoceptor. The compound was developed by Imperial Chemical Industries, which was acquired by AkzoNobel in 2008.

SR 59230A chemical compound

SR 59230A is a selective antagonist of the beta-3 adrenergic receptor, but was subsequently shown to also act at α1 adrenoceptors at high doses. It has been shown to block the hyperthermia produced by MDMA in animal studies.

Adimolol (MEN-935) is antihypertensive agent which acts as a non-selective α1-, α2-, and β-adrenergic receptor antagonist.

Cicloprolol is a beta-adrenoceptor antagonist.

Exaprolol chemical compound

Exaprolol is a beta-adrenoceptor antagonist.

Nifenalol chemical compound

Nifenalol is a beta-adrenoceptor antagonist.

Pamatolol chemical compound

Pamatolol is a beta adrenergic receptor antagonist.

Procinolol chemical compound

Procinolol is a beta adrenergic receptor antagonist.

Spirendolol chemical compound

Spirendolol is a beta adrenergic receptor antagonist.

Tolamolol chemical compound

Tolamolol is a beta adrenergic receptor antagonist.

Capsinolol chemical compound

Capsinolol is a beta blocker derived from nonivamide. It is the first beta blocker with an associated calcitonin gene-related peptide releasing activity in the heart.

Eugenodilol chemical compound

Eugenodilol is a beta blocker derived from eugenol.

References

  1. Sada, H; Harada, S; Ban, T (1983). "Effects of beta-adrenoceptor blocking agents of N-tertiary butyl derivatives on maximum upstroke velocity of action potential in guinea-pig papillary muscles". Naunyn-Schmiedeberg's Archives of Pharmacology. 324 (1): 50–7. doi:10.1007/bf00647838. PMID   6138715.